Daly, C
Conversely, blocking IL-22 production has been shown to worsen the condition of colitis [183, 184]
That said, it is not the best option for everyonethough this is typically for reasons that are not weight-related
The starting dose is usually 0.75 mg, which may be increased to 1.5 mg after at least four weeks if required for adequate glucose control
Working with your PlexusDx clinical team helps identify the dose level that provides weight loss benefits while managing side effects like urinary frequency
Common reasons for denial include: Lack of documented BMI or weight history No record of prior lifestyle interventions or supervised weight loss attempts Medication prescribed for a use not supported by your plan (e.g., weight loss rather than diabetes) How to Improve Your Chances of Approval To improve the likelihood of approval, your provider will typically need to submit: Your current BMI and a record of weight trends Notes documenting prior weight loss attempts (e.g., diet, exercise programs, counseling) A clinical explanation of why medication is needed for your health Any comorbid conditions, such as hypertension, prediabetes, or sleep apnea At OVYVO, we have extensive experience handling prior authorizations